COVID-19: One Year Later Webinar Series
The Global Infectious Institute will highlight sponsored research from across the UVA community that seeks to address the many questions and problems surrounding this pandemic. Register HERE
UVA J-term signature class on Pandemics Beyond the Headlines: COVID-19
GIDI Associate Directors Roseanne Ford and David Leblang bring their respective specialties together to provide students with a broader understanding of the pandemic at a national level. Read more HERE
GIDI honored to be featured at the 2020 American Public Health Association Conference
The Global Infectious Diseases Institute and Director Dr. Alison Criss are honored to be one of the twelve thought leaders featured at the 2020 American Public Health Association conference. This video outlines the mission and vision of GIDI.
Watch Dr. David Robinson's webinar on vaccine development
Did you miss the webinar? Check it out HERE.
Beyond a Vaccine- A&S Magazine article
We are honored that so many GIDI members, featured in this video from UVA Arts & Sciences Magazine, responded to COVID-19 to help the local and global community.
150,000+ Virginians may have had COVID-19, according to UVA Health research
GIDI Collaborative Seed Grant Awardee, Dr. Elizabeth Rogawski McQuade talks with NBC12 about COVID antibodies. Read the full article HERE.
Homepage
News
04/20/2021 - 1:00pm to 2:00pm
It has been just over a year since the World Health Organization declared that the outbreak of the novel coronavirus SARS-CoV-2 (COVID19) constituted a global pandemic on March 11th, 2020. The Global Infectious Institute will highlight sponsored research from across the UVA community that seeks
03/09/2021 - 3:15pm
The Global Infectious Disease Institute (GIDI) announces The Global Infectious Diseases Outreach Fund. The goal of the fund is to support impactful education and outreach in areas surrounding global infectious diseases. Activities supported by this fund should be consistent with GIDI's mission.
Upcoming Events
"We need concerted responses to handling notorious and urgent global infectious diseases."